Endixaprine - Sanofi-Aventis
Alternative Names: SR 41378Latest Information Update: 12 Apr 1995
At a glance
- Originator Sanofi-Synthelabo
- Class Antiepileptic drugs; Anxiolytics; Hypnosedatives; Neuroprotectants; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Anxiety disorders; Epilepsy; Sleep disorders